Mirvetuximab (M9346A) 是一种anti-FOLR1(folate receptor 1) 单克隆抗体。Mirvetuximab 是新型叶酸受体α (FRα) 靶向 ADC (Mirvetuximab soravtansine) 的抗体分子。Mirvetuximab soravtansine 可用于卵巢癌和其他 FRα 阳性的癌症研究。
| 生物活性 | Mirvetuximab (M9346A) is ananti-FOLR1(folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novelfolate receptor alpha(FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positivecancerresearch[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
